Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation.

Area of Science:

• Biochemistry
• Proteomics
• Glycomics

Background:

• Glycoproteins exhibit significant structural diversity crucial for biological functions.
• Glycoproteins hold promise as biomarkers for various diseases.
• Existing methods for glycoproteome analysis face challenges in specificity and sensitivity.

Purpose of the Study:

• To develop and validate a novel functionalized reverse phase protein array (RPPA) for specific glycoprotein capture and profiling, termed polymer-based reverse phase glycoprotein array (polyGPA).
• To assess the specificity, sensitivity, and quantitative capabilities of the polyGPA platform.
• To apply polyGPA and quantitative N-glycoproteomics for validating potential bladder cancer biomarkers in urine.

Main Methods:

• Functionalization of nitrocellulose membranes with globular hydroxyaminodendrimers for covalent capture of preoxidized glycans on glycoproteins.
• Utilizing the same validated antibodies as in RPPA for detecting captured glycoproteins.
• Applying quantitative N-glycoproteomics for comprehensive analysis of captured glycoproteins.

Main Results:

• The polyGPA demonstrated high specificity, sensitivity, and quantitative accuracy in capturing and detecting purified and endogenous α-1-acid glycoprotein (AGP) in human plasma.
• The study successfully validated a panel of glycoproteins as potential biomarkers for bladder cancer using urine samples from patients and healthy individuals.

Conclusions:

• The developed polyGPA platform offers a robust and specific method for glycoproteome analysis.
• PolyGPA holds significant potential for biomarker discovery and validation, particularly in complex biological samples like biofluids.
• This approach advances the utility of glycoproteins as diagnostic and prognostic markers for diseases such as bladder cancer.